Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Halabi

Showing results (81-90 of 282) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B studyCharles J Ryan, Susan Halabi, San-San Ou, et al.
The Journal of Urology|April 5, 2021
Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate CancerSusan Halabi, Shan Jiang, Emi Terasawa, et al.
Clinical Trials (London, England)|July 5, 2022
Landscape of coronavirus disease 2019 clinical trials: New frontiers and challengesSusan Halabi, Jinyi Zhou, Yijie He, et al.
JCO Precision Oncology|March 28, 2024
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate CancerGillian Vandekerkhove, Veda N Giri, Susan Halabi, et al.
Urology|August 11, 2004
Impact of race on survival in men with metastatic hormone-refractory prostate cancerSusan Halabi, Eric J Small, Nicholas J Vogelzang, et al.
JAMA Oncology|July 21, 2022
Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology Trials: A Systematic Review and Meta-analysisPralay Mukhopadhyay, Jiabu Ye, Keaven M Anderson, et al.
NEJM Evidence|February 6, 2024
Bayesian WayC Corey Hardin, Susan Halabi, Daniel Muller, et al.
Clinical Genitourinary Cancer|May 30, 2006
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480Peter A Humphrey, Susan Halabi, Joel Picus, et al.
Plos One|September 17, 2013
Residential mercury contamination in adobe brick homes in Huancavelica, PeruNicole Hagan, Nicholas Robins, Heileen Hsu-Kim, et al.
Pain Medicine (Malden, Mass.)|November 1, 2012
Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903Thomas M Atkinson, Susan Halabi, Antonia V Bennett, et al.
Pageof 29

Showing results (81-90 of 282) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B studyCharles J Ryan, Susan Halabi, San-San Ou, et al.
The Journal of Urology|April 5, 2021
Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate CancerSusan Halabi, Shan Jiang, Emi Terasawa, et al.
Clinical Trials (London, England)|July 5, 2022
Landscape of coronavirus disease 2019 clinical trials: New frontiers and challengesSusan Halabi, Jinyi Zhou, Yijie He, et al.
JCO Precision Oncology|March 28, 2024
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate CancerGillian Vandekerkhove, Veda N Giri, Susan Halabi, et al.
Urology|August 11, 2004
Impact of race on survival in men with metastatic hormone-refractory prostate cancerSusan Halabi, Eric J Small, Nicholas J Vogelzang, et al.
JAMA Oncology|July 21, 2022
Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology Trials: A Systematic Review and Meta-analysisPralay Mukhopadhyay, Jiabu Ye, Keaven M Anderson, et al.
NEJM Evidence|February 6, 2024
Bayesian WayC Corey Hardin, Susan Halabi, Daniel Muller, et al.
Clinical Genitourinary Cancer|May 30, 2006
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480Peter A Humphrey, Susan Halabi, Joel Picus, et al.
Plos One|September 17, 2013
Residential mercury contamination in adobe brick homes in Huancavelica, PeruNicole Hagan, Nicholas Robins, Heileen Hsu-Kim, et al.
Pain Medicine (Malden, Mass.)|November 1, 2012
Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903Thomas M Atkinson, Susan Halabi, Antonia V Bennett, et al.
Pageof 29